Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous venous valve bioprosthesis: initial observations.

Steven S Gale1, Susan Shuman, Hugh G Beebe

  • 1Jobst Vascular Center, Toledo, OH 43606, USA. ssgale@jvc.org

Vascular and Endovascular Surgery
|June 8, 2004
PubMed
Summary

A new percutaneous venous valve bioprosthesis shows promise for treating chronic deep venous insufficiency. This minimally invasive approach aims to restore deep venous system competency, potentially reducing symptoms and improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial.

The New England journal of medicine·2026
Same author

Response to: Diabetic foot ulcer treatment with a multimodal wound matrix.

Journal of wound care·2025
Same author

A novel approach for the treatment of diabetic foot ulcers using a multimodal wound matrix: a clinical study.

Journal of wound care·2024
Same author

Final 3-Year Study Outcomes from the Evaluation of the Zilver Vena Venous Stent for the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction (The VIVO Clinical Study).

Journal of vascular and interventional radiology : JVIR·2024
Same author

Pharmacomechanical Catheter-Directed Thrombolysis With the Bashir Endovascular Catheter for Acute Pulmonary Embolism: The RESCUE Study.

JACC. Cardiovascular interventions·2022
Same author

Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.

Progress in cardiovascular diseases·2022

Area of Science:

  • Vascular Surgery
  • Biomedical Engineering
  • Cardiovascular Research

Background:

  • Chronic deep venous insufficiency is a significant global health issue.
  • Current surgical treatments like valve repair or transplantation are suitable for only a subset of patients.
  • Previous studies show potential benefits and long-term patency with surgically inserted bovine monocusp venous valves in the common femoral vein (CFV).

Purpose of the Study:

  • To evaluate the safety, patency, and efficacy of a novel percutaneous venous valve bioprosthesis.
  • To assess the potential of this device to restore competency in the deep venous system.
  • To explore a less invasive approach for treating deep venous insufficiency.

Main Methods:

  • A Phase I clinical trial was conducted.

Related Experiment Videos

  • Two patients with chronic deep venous insufficiency were treated.
  • A percutaneous venous valve bioprosthesis was implanted distal to the common femoral vein (CFV).

    • Main Results:

    • The study focused on evaluating the safety, patency, and efficacy of the device.
    • Preliminary data from two patients were collected as part of a Phase I trial.
    • The primary objective was to assess the device's ability to restore deep venous system competency.

    Conclusions:

    • The percutaneous venous valve bioprosthesis offers a potential new therapeutic option for patients with chronic deep venous insufficiency.
    • This minimally invasive approach may improve venous hemodynamics and reduce ambulatory venous hypertension.
    • Further research and larger trials are warranted to confirm the long-term benefits and safety profile.